We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Smith & Nephew

Manufactures medical products and devices in the fields of Orthopaedic Reconstruction (joint replacement systems for ... read more Featured Products: More products

Download Mobile App




Dissolvable Nasal Dressing Minimizes Postsurgical Bleeding

By HospiMedica International staff writers
Posted on 14 Oct 2015
A new structural intranasal splint made from CarboxyMethyl Cellulose (CMC) reduces bleeding and prevents adhesions following sinus surgery.

The NasaStent dressing has an open-cell structure and can be easily customized by trimming it to fit the size needs of each patient, with tapered edges for ease of placement into the nasal cavity. More...
Once in place, the soft dressing quickly regains its shape as it conforms to the patient's anatomy, providing sufficient pressure to minimize bleeding and hold the surrounding soft tissues in place as they heal. The dressing’s compressive strength provides a significantly high tissue separation force over a variety of simulated nasal cavity gaps ranging from 7 to 10 mm.

The NasaStent dressing is capable of absorbing up to 16 times its dry weight in fluid, and does not require any special storage conditions for placement. Unlike structural dressings which break down into fragments that must be later removed by a physician, the CMC used in the NasaStent dressing converts into a hydrocolloidal gel after absorbing nasal fluid, and simply drains out as part of the natural outflow. The NasaStent dressing is a product of Smith & Nephew (London, United Kingdom) and has been approved by the US Food and Drug Administration (FDA).

“Smith & Nephew is committed to innovation that improves both the patient and the physician experience, and is proud to offer pioneering technologies such as NasaStent within our leading specialist ENT surgical portfolio,” said Mira Sahney, general manager for ENT and Gynecology at Smith & Nephew.

CMC is a cellulose derivative that is has high viscosity, is nontoxic, and is generally considered to be hypoallergenic. It is used primarily in food as a thickener and to stabilize emulsions in various products, including ice cream. It is also a constituent of many non-food products, such as diet pills, toothpaste, laxatives, water-based paints, detergents, and various paper products. Knitted fabric made into CMC can be used in various medical applications, for example in treating epitaxis (nose bleeding).

Related Links:

Smith & Nephew



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
VTE Prevention System
Flowtron ACS900
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.